X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-19 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale | $34.20 | -2,515 | 72,233 | -3% | -$86,021 | ||||||
2025-03-19 | CRNX | Knight Jeff E. | COO | S - Sale | $34.20 | -7,162 | 87,491 | -8% | -$244,964 | ||||||
2025-03-19 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $34.20 | -5,770 | 108,588 | -5% | -$197,353 | ||||||
2025-03-19 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $34.20 | -17,338 | 1,220,952 | -1% | -$593,017 | ||||||
| D | 2025-02-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $39.07 | -5,000 | 31,748 | -14% | -$195,350 | |||||
| D | 2025-01-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $52.09 | -15,000 | 31,748 | -32% | -$781,350 | |||||
2024-12-02 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $57.57 | -10,000 | 1,149,290 | -1% | -$575,700 | ||||||
2024-11-22 | CRNX | Knight Jeff E. | COO | S - Sale | $56.52 | -501 | 51,653 | -1% | -$28,317 | ||||||
| D | 2024-10-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $54.63 | -14,375 | 28,507 | -34% | -$785,306 | |||||
| D | 2024-09-26 | CRNX | Wilson Marc | CFO | S - Sale+OE | $51.11 | -25,000 | 111,092 | -18% | -$1,277,750 | |||||
2024-09-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $51.50 | -1,035 | 68,576 | -1% | -$53,303 | ||||||
2024-08-26 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $53.19 | -3,000 | 69,611 | -4% | -$159,570 | ||||||
2024-08-12 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $47.68 | -3,000 | 72,611 | -4% | -$143,040 | ||||||
2024-07-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $53.43 | -3,000 | 75,611 | -4% | -$160,290 | ||||||
| D | 2024-07-25 | CRNX | Wilson Marc | CFO | S - Sale+OE | $53.88 | -19,056 | 111,092 | -15% | -$1,026,737 | |||||
| D | 2024-07-15 | CRNX | Knight Jeff E. | COO | S - Sale+OE | $55.00 | -27,000 | 51,653 | -34% | -$1,485,000 | |||||
| D | 2024-07-15 | CRNX | Wilson Marc | CFO | S - Sale+OE | $55.00 | -25,000 | 111,092 | -18% | -$1,375,000 | |||||
2024-07-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $48.55 | -3,000 | 78,611 | -4% | -$145,650 | ||||||
| D | 2024-07-05 | CRNX | Hassard James | Chief Commercial Officer | S - Sale+OE | $44.08 | -15,000 | 29,259 | -34% | -$661,200 | |||||
| D | 2024-07-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.87 | -14,375 | 28,507 | -34% | -$645,006 | |||||
| D | 2024-06-28 | CRNX | Wilson Marc | CFO | S - Sale+OE | $43.61 | -32,129 | 111,092 | -22% | -$1,401,146 | |||||
2024-06-26 | CRNX | Knight Jeff E. | COO | S - Sale | $44.38 | -956 | 52,580 | -2% | -$42,427 | ||||||
2024-06-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $45.37 | -3,000 | 80,643 | -4% | -$136,110 | ||||||
| D | 2024-06-24 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $45.73 | -9,500 | 27,786 | -25% | -$434,435 | |||||
| D | 2024-06-21 | CRNX | Hassard James | Chief Commercial Officer | S - Sale+OE | $44.66 | -15,000 | 29,259 | -34% | -$669,900 | |||||
2024-06-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $43.86 | -3,000 | 83,643 | -3% | -$131,580 | ||||||
2024-05-28 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $47.49 | -3,000 | 86,643 | -3% | -$142,470 | ||||||
2024-05-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $49.43 | -3,000 | 89,643 | -3% | -$148,290 | ||||||
| D | 2024-05-08 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale+OE | $49.40 | -107,448 | 1,159,290 | -8% | -$5,307,931 | |||||
| D | 2024-04-15 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.47 | -14,375 | 27,786 | -34% | -$639,256 | |||||
| D | 2024-04-04 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale+OE | $49.17 | -40,951 | 1,139,640 | -3% | -$2,013,561 | |||||
| D | 2024-03-28 | CRNX | Okey Stephanie | Dir | S - Sale+OE | $46.38 | -17,500 | 6,000 | -74% | -$811,650 | |||||
| D | 2024-03-22 | CRNX | Knight Jeff E. | COO | S - Sale+OE | $44.31 | -32,359 | 52,580 | -38% | -$1,433,675 | |||||
| D | 2024-03-20 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.06 | -15,089 | 27,786 | -35% | -$664,763 | |||||
| D | 2024-03-20 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $44.14 | -60,000 | 18,536 | -76% | -$2,648,150 | |||||
2024-03-19 | CRNX | Wilson Marc | CFO | S - Sale | $42.91 | -6,942 | 110,630 | -6% | -$297,881 | ||||||
2024-01-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $37.26 | -3,000 | 73,298 | -4% | -$111,780 | ||||||
2024-01-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $37.65 | -3,000 | 76,298 | -4% | -$112,950 | ||||||
| D | 2024-01-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $35.00 | -14,375 | 5,911 | -71% | -$503,125 | |||||
| D | 2024-01-02 | CRNX | Wilson Marc | CFO | S - Sale+OE | $35.47 | -10,000 | 96,055 | -9% | -$354,700 | |||||
2023-12-26 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $35.89 | -3,000 | 79,298 | -4% | -$107,670 | ||||||
| D | 2023-12-21 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $34.57 | -9,583 | 5,911 | -62% | -$331,284 | |||||
2023-12-11 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $32.87 | -3,000 | 82,298 | -4% | -$98,610 | ||||||
2023-11-27 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $31.84 | -3,000 | 85,298 | -3% | -$95,520 | ||||||
| DM | 2023-11-02 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale+OE | $30.56 | -200,000 | 1,037,327 | -16% | -$6,111,440 | |||||
| D | 2023-11-01 | CRNX | Wilson Marc | CFO | S - Sale+OE | $28.75 | -10,000 | 95,601 | -9% | -$287,500 | |||||
| D | 2023-10-17 | CRNX | Krasner Alan Seth | Chief Medical Officer | S - Sale+OE | $30.00 | -7,000 | 43,210 | -14% | -$210,000 | |||||
| M | 2023-07-11 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $20.21 | -50,000 | 1,027,327 | -5% | -$1,010,317 | |||||
| D | 2023-06-20 | CRNX | Wilson Marc | CFO | S - Sale+OE | $19.97 | -30,922 | 95,158 | -25% | -$617,403 | |||||
2023-06-16 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $20.81 | -50,000 | 1,077,327 | -4% | -$1,040,500 | ||||||
2023-06-08 | CRNX | Vivaldi Coelho Rogerio | Dir | P - Purchase | $22.06 | +5,000 | 5,000 | New | +$110,300 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |